Esperion Non Current Liabilities Total from 2010 to 2025

ESPR Stock  USD 2.66  0.16  6.40%   
Esperion Therapeutics Non Current Liabilities Total yearly trend continues to be relatively stable with very little volatility. Non Current Liabilities Total is likely to grow to about 510.6 M this year. During the period from 2010 to 2025, Esperion Therapeutics Non Current Liabilities Total destribution of quarterly values had range of 510.6 M from its regression line and mean deviation of  214,605,822. View All Fundamentals
 
Non Current Liabilities Total  
First Reported
2000-03-31
Previous Quarter
481.8 M
Current Value
151.7 M
Quarterly Volatility
225.5 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Esperion Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Esperion Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 66.2 K, Interest Expense of 62.2 M or Gross Profit of 341.8 M, as well as many indicators such as Price To Sales Ratio of 1.18, Dividend Yield of 0.0 or Days Sales Outstanding of 84.78. Esperion financial statements analysis is a perfect complement when working with Esperion Therapeutics Valuation or Volatility modules.
  
Build AI portfolio with Esperion Stock
Check out the analysis of Esperion Therapeutics Correlation against competitors.
To learn how to invest in Esperion Stock, please use our How to Invest in Esperion Therapeutics guide.

Pair Trading with Esperion Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Esperion Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Esperion Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Esperion Stock

  0.77DYAI Dyadic International Earnings Call This WeekPairCorr

Moving against Esperion Stock

  0.86300439 Ningbo MedicalSystemPairCorr
  0.75ABP ABPRO P Symbol ChangePairCorr
  0.63688089 Cabio Biotech WuhanPairCorr
  0.56688217 Shanghai RightongenePairCorr
  0.55OPTI OptiBiotix Health PlcPairCorr
The ability to find closely correlated positions to Esperion Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Esperion Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Esperion Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Esperion Therapeutics to buy it.
The correlation of Esperion Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Esperion Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Esperion Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Esperion Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Esperion Stock Analysis

When running Esperion Therapeutics' price analysis, check to measure Esperion Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Esperion Therapeutics is operating at the current time. Most of Esperion Therapeutics' value examination focuses on studying past and present price action to predict the probability of Esperion Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Esperion Therapeutics' price. Additionally, you may evaluate how the addition of Esperion Therapeutics to your portfolios can decrease your overall portfolio volatility.